DE FALCO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 2.339
NA - Nord America 1.079
AS - Asia 911
SA - Sud America 121
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 18
OC - Oceania 2
Totale 4.542
Nazione #
RU - Federazione Russa 1.713
US - Stati Uniti d'America 1.050
SG - Singapore 295
IT - Italia 195
IE - Irlanda 193
CN - Cina 187
HK - Hong Kong 156
VN - Vietnam 117
BR - Brasile 102
DE - Germania 77
KR - Corea 58
GB - Regno Unito 49
JP - Giappone 26
CA - Canada 24
IN - India 23
FR - Francia 21
FI - Finlandia 14
NL - Olanda 14
AT - Austria 12
GR - Grecia 12
PK - Pakistan 11
PL - Polonia 11
TR - Turchia 8
AR - Argentina 7
BE - Belgio 6
CZ - Repubblica Ceca 5
ZA - Sudafrica 5
IQ - Iraq 4
MA - Marocco 4
MX - Messico 4
PY - Paraguay 4
AZ - Azerbaigian 3
EC - Ecuador 3
ID - Indonesia 3
JO - Giordania 3
SE - Svezia 3
TN - Tunisia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BD - Bangladesh 2
CL - Cile 2
DZ - Algeria 2
ES - Italia 2
GI - Gibilterra 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
SN - Senegal 2
AL - Albania 1
BH - Bahrain 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.470
Città #
Moscow 623
San Jose 195
Dublin 184
Hong Kong 152
Singapore 149
Santa Clara 143
Ashburn 85
Chandler 78
Seoul 58
Dallas 39
Los Angeles 39
Ho Chi Minh City 37
New York 34
Beijing 33
Hefei 31
Hanoi 30
Council Bluffs 27
Naples 25
Ann Arbor 24
Munich 24
Bremen 20
Princeton 19
Roxbury 19
The Dalles 19
Bengaluru 16
São Paulo 12
Cambridge 11
Warsaw 11
Jacksonville 10
Aversa 9
Montreal 9
Caserta 8
Elora 8
Medford 8
Turku 8
Tokyo 7
Amsterdam 6
Brussels 6
Falkenstein 6
Haiphong 6
Hải Dương 6
Istanbul 6
Orem 6
Vienna 6
Brno 5
Des Moines 5
Frankfurt am Main 5
Milan 5
Nuremberg 5
Wilmington 5
Chicago 4
Florence 4
Groningen 4
Hillsboro 4
Johannesburg 4
Rio de Janeiro 4
San Francisco 4
Viterbo 4
Amman 3
Baku 3
Battipaglia 3
Biên Hòa 3
Boston 3
Colle di Val d'Elsa 3
Columbus 3
Da Nang 3
Ercolano 3
Fairfield 3
Helsinki 3
Lappeenranta 3
Lodi 3
London 3
Manchester 3
Nanjing 3
Ninh Bình 3
Piscataway 3
Pomigliano d'Arco 3
Poplar 3
Pune 3
Rome 3
Sennori 3
Shanghai 3
Viareggio 3
Andover 2
Asunción 2
Avellino 2
Bishkek 2
Boardman 2
Brasília 2
Brooklyn 2
Campinas 2
Can Tho 2
Castellammare di Stabia 2
Castello di Brianza 2
Central 2
Chengdu 2
Chennai 2
Cinquevie 2
City of London 2
Dakar 2
Totale 2.423
Nome #
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 185
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 184
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer 179
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance 173
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 164
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR 163
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials 161
Real-world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions 160
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients 160
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer 154
Optimal treatment strategy for metastatic melanoma patients harboring BRAF-V600 mutations 153
Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human BRAFV600E mutant colorectal cancer 152
Biomarker-guided anti-egfr rechallenge therapy in metastatic colorectal cancer 151
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 147
TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities 144
Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: A case report and a review of literature 142
Light alcohol drinking and the risk of cancer development: a controversial relationship 137
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 136
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 132
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype 126
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia 123
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer 122
Temozolomide based treatment in glioblastoma: 6 vs. 12 months 121
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 120
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941 117
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data 113
Feasibility of next-generation sequencing in clinical practice: Results of a pilot study in the Department of Precision Medicine at the University of Campania ' Luigi Vanvitelli' 112
Hypothalamic–pituitary autoimmunity in patients treated with anti-pd-1 and anti-pd-l1 antibodies 112
Treatment of cutaneous melanoma harboring smo p.Gln216arg mutation with imiquimod: An old drug with new results 107
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression 103
How we treat locoregional melanoma 99
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models 95
How we treat metastatic colorectal cancer 95
Totale 4.542
Categoria #
all - tutte 15.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022171 0 10 5 3 33 6 10 8 4 16 28 48
2022/2023370 37 7 11 23 37 32 2 21 174 2 19 5
2023/2024187 26 6 6 9 48 39 2 3 1 5 16 26
2024/2025621 26 19 10 22 88 88 77 61 66 56 63 45
2025/20262.980 116 140 142 118 245 1.600 175 158 112 94 53 27
2026/202775 26 49 0 0 0 0 0 0 0 0 0 0
Totale 4.542